Biological evaluation of novel benzisoxazole derivatives as PPARδ agonists

Bioorganic & Medicinal Chemistry
2011.0

Abstract

We discovered novel peroxisome proliferator-activated receptor δ agonists with a characteristic benzisoxazole ring. Compound 5 exhibited potent human PPARδ transactivation activity. Furthermore, it stimulated the differentiation of oligodendrocyte precursor cells in vitro. This indicates that this potential drug may be effective for the treatment of demyelinating disorders such as multiple sclerosis.

Knowledge Graph

Similar Paper

Biological evaluation of novel benzisoxazole derivatives as PPARδ agonists
Bioorganic & Medicinal Chemistry 2011.0
Synthesis of a novel human PPARδ selective agonist and its stimulatory effect on oligodendrocyte differentiation
Bioorganic & Medicinal Chemistry Letters 2011.0
Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists
Bioorganic & Medicinal Chemistry Letters 2003.0
Discovery and structure-based design of a new series of potent and selective PPARδ agonists utilizing a virtual screening method
Bioorganic & Medicinal Chemistry Letters 2022.0
Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)—synthesis and biological activity
Bioorganic & Medicinal Chemistry Letters 2003.0
Benzoxazinones as PPARγ agonists. part 1: SAR of three aromatic regions
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis and Evaluation of PPARδ Agonists That Promote Osteogenesis in a Human Mesenchymal Stem Cell Culture and in a Mouse Model of Human Osteoporosis
Journal of Medicinal Chemistry 2021.0
Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist
Journal of Natural Products 2016.0
Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists
Bioorganic & Medicinal Chemistry 2015.0
Pharmacophore elucidation of phosphoiodyn A – Potent and selective peroxisome proliferator-activated receptor β/δ agonists with neuroprotective activity
Bioorganic & Medicinal Chemistry Letters 2016.0